Work

Abstract LB138: A novel dual-TOP1i ADC targeting NaPi2b designed for high efficacy and tolerability

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb138

Authors: Isabella Attinger-Toller, Philipp Probst, Romain Bertrand, Emma Renard, Lia Kallenberger, Ramona Stark, Patrick Maurhofer, Dragan Grabulovski, Bernd Schlereth, Philipp R. Spycher

Institution: Araris Biotech AG (Switzerland)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821532

Cites:

Cited by: 1

Related to: 10